Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2019 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Discuss 2019 Second Quarter Financial Results on August 9, 2019 Conference Call

HOUSTON, July 30, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically...
June 19, 2019 07:00 ET | Source: PLx Pharma Inc.

PLx Pharma on Track for VAZALORE Regulatory Pathway

HOUSTON, June 19, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically...
June 10, 2019 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference

HOUSTON, June 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically...
May 10, 2019 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports First Quarter 2019 Results

HOUSTON, May 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically...
May 02, 2019 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Discuss 2019 First Quarter Financial Results on May 10, 2019 Conference Call

HOUSTON, May 02, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically...
March 08, 2019 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports Fourth Quarter 2018 Results

– Company Completes Successful $15 Million Financing – HOUSTON, March 08, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical...
February 25, 2019 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call

HOUSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
February 20, 2019 16:55 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Announces Completion of $15 Million Convertible Preferred Stock Financing

HOUSTON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
February 14, 2019 11:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Announces Adjournment of Special Meeting of Stockholders

HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
December 20, 2018 19:32 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Announces $15 Million Convertible Preferred Stock Financing

HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...